Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04586335
Title Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ShangHai HaiHe Pharmaceutical

Advanced Solid Tumor

fallopian tube cancer

peritoneum cancer

ovarian serous carcinoma


CYH33 + Olaparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST